US › Healthcare

Celularity Inc (CELU)

US · Healthcare · Biotechnology

$1.25-6.02%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$3.8M

Revenue YoY

-32.9%

Net profit

$675,000

EPS

$0.02

Net margin

17.6%

Key statistics

Market cap

$43.2M

Forward P/E

0.0

P/B

9.89

Book value

$-1.21

EPS (TTM)

$-2.52

52-week high

$2.55

52-week low

$0.56

50-day MA

$1.25

200-day MA

$1.10

Beta

0.78

Analyst view

with an average price target of $2.50.

Shareholding

Insiders

33.17%

Institutions

11.43%

Largest institutional holders

Fund	Stake
C V Starr & Co Inc	2.35%
Vanguard Capital Management, LLC	1.91%
Geode Capital Management, LLC	0.52%
Citadel Advisors Llc	0.31%
Vanguard Fiduciary Trust Co	0.25%
BlackRock Inc	0.24%
State Street Corp	0.18%
HRT FINANCIAL LLC	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Celularity Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.